Thromboembolic diseases in neonates and children

Pathophysiology of Haemostasis and Thrombosis

Volumn 33, Issue 5-6, 2003, Pages 269-274

  Nowak Göttl, Ulrike ^a   Duering, Christine ^a   Kempf Bielack, Beate ^a   Sträter, Ronald ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Children; Thrombophilia; Thrombosis

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTITHROMBIN; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; FIBRINOGEN; HOMOCYSTEINE; LIPOPROTEIN; PLASMINOGEN; PROTEIN C; PROTEIN S; PROTHROMBIN;

AGE DISTRIBUTION; ANTICOAGULATION; CAVA VEIN OBSTRUCTION; CHILDHOOD DISEASE; CONFERENCE PAPER; DNA DETERMINATION; DNA POLYMORPHISM; ETHNOLOGY; FULMINATING PURPURA; GENE MUTATION; GENETIC SCREENING; GENOTYPE; HUMAN; KIDNEY VEIN; LABORATORY TEST; NEWBORN DISEASE; PRIORITY JOURNAL; PROTEIN DETERMINATION; RISK FACTOR; SCREENING TEST; STROKE; THROMBOEMBOLISM;

CHILD; GENETIC SCREENING; HUMANS; INFANT, NEWBORN; RISK FACTORS; THROMBOEMBOLISM;

EID: 14044253445     PISSN: 14248832     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083813     Document Type: Conference Paper

References (79)

1. Andrew M. Developmental hemostasis: Relevance to thromboembolic complications in pediatric patients. Thromb Haemost 1995; 74: 415-425.
2. Andrew M, David M, Adams M, et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian registry of VTE. Blood 1994; 83: 1251-1257.
3. Schmidt B, Andrew M. Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics 1995; 96: 939-943.
4. Nowak-Göttl U, von Kries R, Göbel U. Neonatal symptomatic thromboembolism in Germany: two year survey. Arch Dis Child Fetal Neonatal Ed 1997; 76: F163-167.
5. Massicotte MP, Dix D, Monagle P, Adams M, Andrew M. Central venous catheter related thrombosis in children: Analysis of the Canadian Registry of venous thromboembolic complications. J Pediatr 1998; 133: 770-776.
6. Monagle P, Adams M, Mahoney M, et al. Outcome of pediatric thromboembolic disease: a report from the Canadian childhood thrombophilia registry. Pediatr Res 2000; 47: 763-766.
7. Nowak-Göttl U, Dübbers A, Kececioglu D, et al. Factor V Leiden, protein C, and lipoprotein (a) in catheter-related thrombosis in childhood - a prospective study. J Pediatr 1997; 131: 608-612.
8. Vitiello R, McCrindle BW, Nykanen D, Freedom RM, Benson LN. Complications associated with pediatric cardiac catheterization. J Am Coll Cardiol 1998; 32: 1433-1440.
9. Salonvaara M, Riikonen P, Kekomaki R, Heinonen K. Clinically symptomatic central venous catheter-related deep venous thrombosis in newborns. Acta Paediatr 1999;88:642-646.
10. Boo NY, Wong NC, Zulkifli SS, Lye MS. Risk factors associated with umbilical vascular catheter-associated thrombosis in newborn infants. J Pediatr Child Health 1999;35:460-465.
11. Uttenreuther-Fischer MM, Vetter B, Hellmann C, et al. Paediatric thrombo-embolism: the influence of non-genetic factors and the role of activated protein C resistance and protein C deficiency. Eur J Pediatr 1997;156:277-281.
12. Seixas CA, Hessel G, Ribeiro CC, Arruda VR, Annichino-Bizzacchi JM. Factor V Leiden is not common in children with portal vein thrombosis. Thromb Haemost 1997;77:258-261.
13. Schwartz DS, Gettner PA, Konstantino MM, et al. Umbilical venous catheterization and the risk of portal vein thrombosis. J Pediatr 1997;131:760-762.
14. Grandas OH, Klar M, Goldman MH, Filston HC. Deep venous thrombosis in the pediatric trauma population: an unusual event: report of three cases. Am Surg 2000;66:273-276.
15. Kaplan DM, Fliss DM, Peiser Y, Greenberg D, Leiberman A. Internal jugular vein thrombosis in a child due to a "pencil point injury" of the palate. Int J Pediatr Otorhinolaryngol 1998;44:183-187.
16. Eire PF, Vallejo D, Sastre JL, Villaamil R, Rodriguez MA, Garrido M. An unusual complication of appendicitis in childhood. Eur J Pediatr Surg 1999;9:351-352.
17. Sifontes MT, Nuss R, Hunger SP, Wilimas J, Jacobson LJ, Manco-Johnson MJ. The factor V Leiden mutation in children with cancer and thrombosis. Br J Haematol 1997;96:484-489.
18. Mitchell L, Hoogendoom H, Giles AR, Vegh P, Andrew M. Increased endogenous thrombin generation in children with acute lymphoblastic leukemia: risk of thrombotic complications in L-Asparaginase-induced antithrombin III deficiency. Blood 1994;83:386-391.
19. Nowak-Göttl U, Wermes C, Junker R, et al. Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factors. Blood 1999;93:1595-1599.
20. Kocak U, Gursel T, Ozturk G, Kantarci S. Thrombosis during all-trans-retinoic acid therapy in a child with acute promyelocytic leukemia and factor VQ 506 mutation. Pediatr Hematol Oncol 2000;17:177-178.
21. Schlegel N. Thromboembolic risks and complications in nephrotic children. Semin Thromb Hemost 1997;23:271-280.
22. Fabri D, Belangero VM, Annichino-Bizzachi JM, Arruda VR. Inherited risk factors for thrombophilia in children with nephrotic syndrome. Eur J Pediatr 1998;157:939-942.
23. Mocan H, Beattie TJ, Murphy AV. Renal venous thrombosis in infancy: long-term follow-up. Pediatr Nephrol 1991;5:45-49.
24. Bökenkamp A, von Kries R, Nowak-Göttl U, Göbel U, Hoyer PF. Neonatal renal venous thrombosis in Germany between 1992 and 1994: epidemiology, treatment and outcome. Eur J Pediatr 2000;159:44-48.
25. Oh J, Schäfer F, Veldmann A, et al. Heterozygous prothrombin gene mutation: a new risk factor for early renal allograft thrombosis. Transplantation 1999;68:575-578.
26. Heidenreich S, Dercken C, August C, Koch HG, Nowak-Göttl U. High rate of acute rejections in renal allograft recipients with thrombophilic risk factors. J Am Soc Nephrol 1998;9:1309-1313.
27. Sträter R, Vielhaber H, Kassenböhmer R, von Kries R, Göbel U, Nowak-Göttl U. Genetic risk factors of thrombophilia in ischaemic childhood stroke of cardiac origin. A prospective ESPED survey. Eur J Pediatr 1999;158;S122-125.
28. Worth LL, Hoots WK. Development of a subdural vein thrombosis following aggressive factor VII replacement for postnatal intracranial haemorrhage in a homozygous factor VII-deficient infant. Haemophilia 1998;4:757-761.
29. Escuriola Ettingshausen C, Martinez Saguer I, Kreuz W. Portal vein thrombosis in a patient with severe haemophilia A and F V G1691A mutation during continuous infusion of F VIII after intramural jejunal bleeding - successful thrombolysis under heparin therapy. Eur J Pediatr 1999;158:S180-182.
30. Escuriola Ettingshausen C, Halimeh S, Kurnik K, et al. Symptomatic onset of severe hemophilia A in childhood is dependent on the presence of prothrombotic risk factors. Thromb Haemost 2001;85:218-220.
31. Ranze O, Ranze P, Magnani HM, Greinacher A. Heparin-induced thrombocytopenia in paediatric patients. A review of the literature ana a new case treated with danaparoid sodium. Eur J Pediatr 1999;158:S130-133.
32. Lane A, Grant PJ. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood 2000;95:1517-1526.
33. Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med 2001; 344: 1222-1231.
34. Nowak-Göttl U, Junker R, Hartmeier M, et al. Increased lipoprotein (a) is an important risk factor for venous thromboembolism in childhood. Circulation 1999;100:743-748.
35. Nowak-Göttl U, Sträter R, Heinecke A, et al. Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin and methylenetetrahydrofolate reductase are risk factors of ischaemic stroke in childhood. Blood 1999;94:3678-3682.
36. Nowak-Göttl U, Junker R, Kreuz W, et al. Risk of recurrent thrombosis in children with combined prothrombotic risk factors. Blood 2001;97:858-862.
37. Depka von M, Nowak-Göttl U, Eisert R, et al. Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism. Blood 2000;96:3364-3368.
38. Seligsohn U, Zivelin A. Thrombophilia as a multigenetic disorder. Thromb Haemost 1997;78:297-301.
39. Salomon O, Steinberg DM, Zivelin A, et al. Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism - Prevalence and risk assessment. Arterioscler Thromb Vasc Biol 1999;19:511-518.
40. Formstone CJ, Hallam PJ, Tuddenham EG, et al. Severe perinatal thrombosis in double and triple heterozygous offspring of a family segregating two independent protein S mutations and a protein C mutation. Blood 1996;87:3731-3737.
41. Brenner B, Zivelin A, Lanir N, Greengard JS, Griffin JH, Seligsohn U. Venous thromboembolism associated with double heterozygosity for R506Q mutation of factor V and for T298M mutation of protein C in a large family of a previously described homozygous protein C deficient newborn with massive thrombosis. Blood 1996;88:877-880.
42. Debus O, Koch HG, Kurlemann G, et al. Factor V Leiden and genetic defects of thrombophilia in childhood porencephaly. Arch Dis Child Fetal Neonatal Ed 1998;78:F121-124.
43. Günther G, Junker R, Sträter R, et al. Symptomatic ischemic stroke in full-term neonates: Role of acquired and genetic prothrombotic risk factors. Stroke 2000;31: 2437-2441.
44. DeVeber G, Monagle P, Chan A, et al. Prothrombotic disorders in infants and children with cerebral thromboembolism. Arch Neurol 1998;55:1539-1543.
45. Heller C, Heinecke A, Junker R, et al. Cerebral venous thrombosis in children. A multifactorial origin. Circulation 2003;1362-1367.
46. Hagstrom JN, Walter J, Bluebond-Langner R, Amatniek JC, Manno CS, High KA. Prevalence of the factor V Leiden mutation in children and neonates with thromboembolic disease. J Pediatr 1998;133:777-781.
47. Heller C, Schobess R, Kurnik K, et al. Abdominal venous thrombosis in neonates and infants: Role of prothrombotic risk factors - a multicentre case-control study. Br J Haematol 2000; 111: 534-539.
48. Seligsohn U, Berger A, Abend M, et al. Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn. N Engl j Med 1984; 310: 559-562
49. Marciniak E, Wilson HD, Marlar RA. Neonatal purpura fulminans: a genetic disorder related to the absence of protein C in blood. Blood 1985; 65: 15-20.
50. Marlar RA, Mongomery RR, Broekmans AW. Diagnosis and treatment of homozygous protein C-deficiency. Report of the Working Party on Homozygous Protein C Deficiency of the Subcommittee on Protein C and Protein S. International Committee on Thrombosis and Haemostasis. J Pediatr 1989;114:528-534.
51. Mahasandana C, Suvatte V, Marlar RA, Manco-Johnson MJ, Jacobson LJ, Hathaway WE. Neonatal purpura fulminans associated with homozygous protein S deficiency. Lancet 1990;335:61-62.
52. Pipe SW, Schmaier AH, Nichols WC, et al. Neonatal purpura fulminans in association with factor V R506Q mutation. J Pediatr 1996;128:706-709.
53. Manco-Johnson MJ, Nuss R, Key N, et al. Lupus anticoagulant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis. J Pediatr 1996;128:319-323.
54. Male C, Mitchell L, Julian J, et al. Acquired activated protein C resistance is associated with lupus anticoagulants and thrombotic events in paediatric patients with systemic lupus erythematosus. Blood 2001;97:844-849.
55. Ehrenforth S, Junker R, Koch HG, et al. Multicentre evaluation of combined prothrombotic defects with thrombophilia in childhood. Eur J Pediatr 1999;158:S97-104.
56. Junker R, Koch HG, Auberger K, Münchow N, Ehrenforth S, Nowak-Göttl U. Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia. Arterioscler Thromb Vase Biol 1999;19:2568-2572.
57. Bonduel M, Hepner M, Sciuccati G, Torres AF, Pieroni G, Frontroth JP. Prothrombotic abnormalities in children with venous thromboembolism. J Pediatr Hematol Oncol 2000;22:66-72.
58. Becker S, Heller C, Gropp F, Scharrer I, Kreuz W. Thrombophilic disorders in children with cerebral infarction. Lancet 1998;352:1756-1757.
59. Ganesan V, Kelsey H, Cookson J, Osborn A, Kirkham FJ. Activated protein C resistance in childhood stroke. Lancet 1996; 347: 260.
60. Riikonen RS, Vahtera EM, Kekomäki RM. Physiological anticoagulants and activated protein C resistance in childhood stroke. Acta Paediatr 1996;85:242-244
61. Zenz W, Bodo Z, Plotho J, et al. Factor V Leiden and prothrombin gene G20210A variant in children with ischaemic stroke. Thromb Haemost 1998;80:763-766.
62. McColl MD, Chalmers EA, Thomas A, et al. Factor V Leiden, prothrombin 20210GA and the MTHFR C677T mutations in childhood stroke. Thromb Haemost 1999;81:690-694.
63. Van Beynum IM, Smeitink JA, den Heijer M, te Poele Pothoff MT, Blom HJ. Hyperhomocysteinemia: a risk for ischemic stroke in children. Circulation 1999;99:2070-2072.
64. Kenet G, Sadetzki S, Murad H, et al. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke 2000;31:1283-1288
65. Heller C, Becker S, Scharrer I, Kreuz W. Prothrombotic risk factors in childhood stroke and venous thrombosis. Eur J Pediatr 1999;158:S117-121.
66. Nowak-Göttl U, Kohlhase B, Vielhaber H, Aschka I, Schneppenheim R, Jürgens H. APC-resistance in neonates and infants: Adjustment of an aPTT-based method. Thromb Res 1996;81:665-670.
67. Sifontes MT, Nuss R, Hunger SP, Jacobson LJ, Waters J, Manco-Johnson MJ. Correlation between the functional assay for activated protein C resistance and factor V Leiden in the neonate. Pediatr Res 1997;42:776-778.
68. Marcovina SM, Albers JJ, Scanu AM, et al. Use of a reference material proposed by the International Federation of Clinical Chemistry and Laboratory Medicine to evaluate analytical methods for the determination of plasma lipoprotein(a). Clin Chem 2000;46:1956-1967.
69. Marcovina SM, Hobbs HH, Albers JJ. Relation between number of apolipoprotein (a) kringle 4 repeats and mobility of isoforms in agarose gel: basis for a standardized isoform nomenclature. Clin Chem 1996;42:436-439.
70. Williams E. Disseminated intravascular coagulation. Loscalzo J, Schafer AI, eds. Thrombosis and Hemorrhage. 2nd ed. Baltimore, Philadelphia, London, Paris, Bankok, Buenos Aires, Hong Kong, Munich, Sydney, Tokyo, Wroclaw: Williams & Willkins 1998:963-985.
71. Kosch A, Junker R, Kurnik K, et al. Prothrombotic risk factors in children with spontaneous venous thrombosis and their asymptomatic parents: a family study. Thromb Res 2000;99:531-537.
72. Wang XL, Wilcken DEL, Dudman NPB. Early expression of the apolipoprotein (a) gene: relationships between infants' and their parents' serum apolipoprotein (a) levels. Pediatrics 1992;89:401-406.
73. Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L. Maturation of the hemostatic system during childhood. Blood 1992; 80: 1998-2005.
74. Andrew M. The relevance of developmental hemostasis to hemorrhagic disorders of newborns. Sem Perinatol 1997;21:70-85.
75. Rees DC. The population genetics of factor V Leiden (Arg 506 Gln). Review. Br J Haematol 1996;95:579-586.
76. Zivelin A, Rosenberg N, Faier S, et al. A single genetic origin for the common prothrombotic G20210A polymorphism in the prothrombin gene. Blood 1998;92:1119-1124.
77. Conroy JM, Trivedi G, Sovd T, Caggana M. The allele frequency of mutations in four genes that confer enhanced susceptibility to venous thromboembolism in an unselected group of New York state newborns. Thromb Res 2000;99:317-324.
78. Helmhold M, Bigge J, Muche R, et al. Contribution of the apo(a) phenotype to plasma Lp(a) concentrations shows considerable ethnic variation. J Lipid Res 1991;32:1919-1928.
79. Kosch A, Koch HG, Heinecke A, Kurnik K, Heller C, Nowak-Göttl U; Childhood Thrombophilia Study Group. Increased fasting total homocysteine plasma levels as a risk factor for thromboembolism in children. Thromb Haemost. 2004;91:308-314.